Condition: Bone Marrow Transplant (BMT) · Sponsor: Ossium Health, Inc.
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
This description comes directly from the study's public registry record.
Preethi Prasad, Senior Director Clinical Operations · 415-513-5535 · preethi.prasad@ossiumhealth.com
Always discuss trial participation with your own doctor first.
| University of Alabama, Birmingham | Birmingham, Alabama, United States | Recruiting |
| Henry Ford Health | Detroit, Michigan, United States | Recruiting |
| The Ohio State University Medical Center | Columbus, Ohio, United States | Recruiting |
| Tristar Centennial Medical Center | Nashville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07145411